Blood Test Tracking for Psoriasis and Psoriatic Disease
Psoriasis is more than a skin condition — it is a systemic inflammatory disease with well-documented links to metabolic syndrome, cardiovascular disease, and non-alcoholic fatty liver disease. Regular blood test monitoring helps you and your dermatologist or rheumatologist track these comorbidities and the metabolic effects of psoriasis treatments.
Psoriasis as a Systemic Inflammatory Disease: Why Metabolic Markers Matter
Population studies consistently demonstrate that psoriasis, particularly moderate to severe disease, is associated with metabolic syndrome at rates substantially higher than the general population. The underlying mechanism is bidirectional: chronic skin inflammation drives systemic inflammation via cytokines such as TNF-alpha and IL-17, which in turn promote insulin resistance, dyslipidemia, and visceral adiposity. At the same time, obesity and metabolic dysfunction worsen psoriasis severity — creating a feedback loop that blood biomarkers can help you monitor and manage.
The metabolic markers most relevant to psoriasis surveillance are fasting glucose, fasting insulin, and magnesium. Fasting insulin, in particular, can reveal insulin resistance well before fasting glucose becomes abnormal — an important distinction given that psoriasis patients with insulin resistance are at higher cardiometabolic risk even when glucose appears normal. HbA1c and a lipid panel, while not on Health3 reference pages, are important complementary tests your GP or dermatologist should include in annual metabolic review. The metabolic health topic in Health3 aggregates your trackable markers into a single score. Read the blood sugar markers guide for context on interpreting glucose and insulin together.
Tracking these markers every six months — or more frequently during biologic initiation — gives you a longitudinal dataset that reflects the actual metabolic trajectory of your disease, rather than a single snapshot at an annual appointment.
Vitamin D in Psoriasis: Immune Regulation Beyond Bone Health
Vitamin D plays a recognized role in skin cell (keratinocyte) differentiation and the regulation of immune pathways implicated in psoriasis pathogenesis. Studies consistently find lower serum 25-OH vitamin D levels in psoriasis patients compared with controls, and several observational studies have found associations between lower vitamin D and higher psoriasis severity scores. Topical vitamin D analogues (calcipotriol, calcitriol) are established psoriasis treatments — reflecting the biological plausibility of the vitamin D–psoriasis relationship at the tissue level.
Beyond the immune rationale, sun avoidance — sometimes adopted by patients who have photosensitive reactions to certain psoriasis medications or who are simply avoiding the UV exposure that can trigger Koebner reactions — further depletes systemic vitamin D. And the metabolic syndrome comorbidity adds another layer: insulin resistance independently impairs vitamin D status by disrupting its transport and metabolism.
Tracking vitamin D regularly in Health3 allows you to confirm that supplementation is maintaining levels in the range your dermatologist recommends — not merely within the reference interval but at the level evidence supports for immune-relevant outcomes. Health3 flags the distinction between normal and optimal ranges. The vitamin D optimal levels guide explains this distinction in detail, and the bone health topic gives an aggregated view alongside calcium and magnesium.
Monitoring Liver and Metabolic Markers During Biologic and Conventional Therapy
Psoriasis treatment introduces its own blood monitoring requirements. Methotrexate — used in moderate-to-severe psoriasis, especially with psoriatic arthritis — requires periodic liver function tests (ALT, AST) due to its hepatotoxic potential, as well as folate monitoring given its mechanism of action. HbA1c monitoring is relevant for patients on long-term corticosteroids or with existing insulin resistance. Biologic agents such as anti-IL-17, anti-IL-23, and anti-TNF therapies are generally associated with fewer metabolic blood test requirements, but hepatic safety checks remain part of some monitoring protocols — your dermatologist or rheumatologist manages these.
Ferritin serves double duty in psoriasis monitoring: it reflects both systemic inflammation and — when elevated alongside high insulin — is an early signal of non-alcoholic fatty liver disease (NAFLD), which is more prevalent in psoriasis patients than the general population. A persistently elevated ferritin warrants further evaluation by your doctor. The ferritin levels guide explains the multiple contexts in which ferritin rises and how to interpret it alongside other markers.
Homocysteine rounds out the cardiovascular monitoring picture in psoriasis — elevated levels independently predict cardiovascular events, and psoriasis patients are at elevated baseline cardiovascular risk. B12 and folate status directly influence homocysteine levels, creating an actionable link between nutritional monitoring and cardiovascular risk reduction. The cardiovascular health topic in Health3 aggregates these markers for a high-level view.
Building a Monitoring Routine That Works Between Skin Appointments
Dermatology follow-up for psoriasis is often focused on skin clearance assessment and biologic dosing adjustments rather than metabolic blood review. GPs typically handle the metabolic monitoring — lipids, HbA1c, blood pressure — but this monitoring can fall through the cracks between annual reviews, particularly in patients whose psoriasis is managed primarily by a dermatologist. Health3 gives you a structured way to organize and trend the blood results you do have, ensuring that metabolic drift is visible over time.
Every time you receive blood results — from your GP, from a pre-biologic screen, or from private testing — you can log them in Health3 and compare them against your previous values. Tracking fasting glucose, insulin, vitamin D, ferritin, homocysteine, and magnesium longitudinally reveals whether your cardiometabolic risk profile is improving or worsening alongside skin treatment. The how often to get blood work guide and frequency tool help you plan an appropriate monitoring cadence.
Exporting your Health3 history as a PDF before dermatology or rheumatology appointments ensures your specialist has a metabolic context for skin and joint treatment decisions — particularly relevant when considering which biologic is most appropriate given your cardiovascular and metabolic profile.
Medical disclaimer: Health3 is a biomarker tracking and educational tool, not a medical device. It does not diagnose psoriasis, assess skin clearance, or recommend changes to biologic or systemic therapy. All treatment decisions — including regarding methotrexate, biologics, and corticosteroids — must be made by your dermatologist or rheumatologist. Liver function test monitoring for systemic therapies should follow your prescribing physician's protocol.
Key Biomarkers to Track
| Biomarker | Why It Matters |
|---|---|
| Vitamin D (25-OH) | Vitamin D deficiency is significantly more prevalent in psoriasis patients; vitamin D has known roles in skin cell differentiation and immune modulation relevant to the disease. |
| Blood Glucose | Type 2 diabetes is significantly more likely in psoriasis patients than the general population — meta-analyses estimate approximately 59–76% higher risk overall, rising to approximately 97–110% higher in severe disease; the association is strongest in those with extensive skin involvement. Fasting glucose is a frontline marker for metabolic comorbidity surveillance. |
| Fasting Insulin | Insulin resistance is a key feature of the metabolic syndrome strongly associated with psoriasis; fasting insulin tracking can reveal insulin resistance before glucose becomes overtly abnormal. |
| Ferritin | Elevated ferritin can indicate both systemic inflammation and insulin resistance — both relevant in psoriasis — and is also an early marker of non-alcoholic fatty liver disease. |
| Homocysteine | Psoriasis patients have elevated cardiovascular risk; homocysteine is a modifiable cardiovascular risk marker that responds to B-vitamin optimization. |
| Magnesium | Magnesium deficiency is associated with insulin resistance and systemic inflammation; tracking magnesium supports the metabolic monitoring relevant to psoriasis comorbidities. |
Health Topics That Matter Most
- Metabolic Health — Psoriasis is independently associated with metabolic syndrome, insulin resistance, and type 2 diabetes; metabolic biomarker monitoring is part of comprehensive psoriasis care.
- Cardiovascular Health — The systemic inflammatory burden of psoriasis elevates cardiovascular risk independently of traditional risk factors; homocysteine and glucose tracking are directly relevant.
- Inflammation & Immune Health — CRP and systemic inflammation markers reflect psoriasis disease burden; nutritional markers including vitamin D and ferritin interact with the inflammatory state.
- Bone Health — Vitamin D is both a bone health marker and a marker with immune relevance in psoriasis; monitoring it serves dual purposes in long-term care.
How Health3 Helps
- Biomarker Trending: Track how your biomarker values change over time with visual trend charts. Spot patterns that single snapshots miss.
- Test Comparison: Compare two blood tests side by side to see exactly what changed between draws.
- Optimal vs Normal Ranges: See whether your values are merely normal or truly optimal. Health3 distinguishes between standard lab ranges and evidence-based optimal ranges.
- Weekly Insights: Receive personalized, science-backed insights each week based on your latest biomarker values.
- PDF Export: Export your test results and full history as clean, branded PDF reports to share with your doctor.
Key Takeaway: Psoriasis management extends well beyond skin clearance to include cardiovascular and metabolic risk monitoring. Tracking vitamin D, glucose, insulin, ferritin, and homocysteine between dermatology appointments helps you stay ahead of the systemic comorbidities that psoriasis is known to drive — and supports safer monitoring of biologic and conventional therapies.
Frequently Asked Questions
Track Your Biomarkers With Health3
Scan your lab results, explore biomarker interactions, and track trends over time with the Health3 app.
Related Pages
Medical Disclaimer: This article is for informational and educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making changes to your health regimen. Read our full Content Standards & Medical Disclaimer.